Apex Healthcare Berhad (KLSE:AHEALTH)

Apex Healthcare Berhad Income Statement

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	970.14	961.78	936.17	877.74	770.76	698.73
Revenue Growth (YoY)	0.61%	2.74%	6.66%	13.88%	10.31%	1.44%
Cost of Revenue	742.97	736.18	721.34	680.15	609.78	550.51
Gross Profit	227.18	225.59	214.83	197.59	160.97	148.22
Selling, General & Admin	129.42	128.26	123.86	112	98.08	93.29
Other Operating Expenses	-1.53	-6.78	12.2	-2.14	-2.77	-4.75
Operating Expenses	127.89	121.47	136.06	109.87	95.31	88.54
Operating Income	99.28	104.12	78.77	87.73	65.66	59.67
Interest Expense	-2.04	-1.4	-0.56	-0.76	-0.86	-1.15
Interest & Investment Income	7.81	7.81	6.86	1.62	1.82	1.79
Earnings From Equity Investments	-14.42	-9.78	336.4	29.57	7.1	8.66
Currency Exchange Gain (Loss)	0.25	0.25	1.55	1.51	1.25	0.99
EBT Excluding Unusual Items	90.87	100.99	423.02	119.66	74.96	69.97
Gain (Loss) on Sale of Assets	0.2	0.2	0.28	0.69	0.18	0.18
Pretax Income	91.08	101.2	423.31	120.36	75.41	70.17
Income Tax Expense	25.62	24.66	25.32	19.38	15.98	14.16
Earnings From Continuing Operations	65.46	76.54	397.99	100.97	59.44	56.01
Minority Interest in Earnings	-	-	-	0	-0.02	0.01
Net Income	65.46	76.54	397.99	100.97	59.42	56.02
Net Income to Common	65.46	76.54	397.99	100.97	59.42	56.02
Net Income Growth	-21.27%	-80.77%	294.15%	69.94%	6.06%	6.20%
Shares Outstanding (Basic)	716	715	714	711	710	710
Shares Outstanding (Diluted)	716	715	715	714	711	712
Shares Change (YoY)	0.07%	0.09%	0.16%	0.33%	-0.14%	0.34%
EPS (Basic)	0.09	0.11	0.56	0.14	0.08	0.08
EPS (Diluted)	0.09	0.11	0.56	0.14	0.08	0.08
EPS Growth	-21.27%	-80.78%	293.50%	69.46%	6.10%	5.92%
Free Cash Flow	120.17	41.03	39.26	41.76	50.85	69.66
Free Cash Flow Per Share	0.17	0.06	0.06	0.06	0.07	0.10
Dividend Per Share	0.060	0.090	0.050	0.043	0.037	0.030
Dividend Growth	-29.41%	80.00%	15.47%	17.98%	22.33%	21.46%
Gross Margin	23.42%	23.46%	22.95%	22.51%	20.89%	21.21%
Operating Margin	10.23%	10.83%	8.41%	9.99%	8.52%	8.54%
Profit Margin	6.75%	7.96%	42.51%	11.50%	7.71%	8.02%
Free Cash Flow Margin	12.39%	4.27%	4.19%	4.76%	6.60%	9.97%
EBITDA	119.57	123.09	95.47	103.03	80.8	74.88
EBITDA Margin	12.32%	12.80%	10.20%	11.74%	10.48%	10.72%
D&A For EBITDA	20.29	18.97	16.69	15.31	15.14	15.21
EBIT	99.28	104.12	78.77	87.73	65.66	59.67
EBIT Margin	10.23%	10.83%	8.41%	9.99%	8.52%	8.54%
Effective Tax Rate	28.13%	24.36%	5.98%	16.11%	21.18%	20.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.